These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23765251)

  • 1. The role of OCT4 immunohistochemistry in evaluation of retroperitoneal lymph node dissections: a pilot study.
    Idrees MT; Williamson SR; Kieffer TW; Cheng L
    Mod Pathol; 2013 Dec; 26(12):1613-9. PubMed ID: 23765251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT4 immunohistochemistry after staging laparoscopic retroperitoneal lymphadenectomy for testicular tumor.
    Knežević N; Kuliš T; Penezić L; Ćorić M; Krhen I; Kaštelan Ž
    Acta Clin Croat; 2019 Jun; 58(2):343-347. PubMed ID: 31819332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?
    Riggs SB; Burgess EF; Gaston KE; Merwarth CA; Raghavan D
    Oncologist; 2014 May; 19(5):498-506. PubMed ID: 24718515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour.
    Oing C; Rescigno P; Paffenholz P; Heinzelbecker J; Patrikidou A; Matulewicz RS; Huddart R
    Eur Urol Focus; 2024 May; 10(3):361-363. PubMed ID: 39095218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma.
    Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
    Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoendoscopic single-site retroperitoneal lymph node dissection in non-seminomatous germ cell malignancy.
    Angulo JC; Redondo C; Gimbernat H; Ramón de Fata F; García-Tello A; García-Mediero JM
    Actas Urol Esp; 2015 May; 39(4):253-8. PubMed ID: 25438690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
    Matulewicz RS; Benfante N; Funt SA; Feldman DR; Carver B; Doudt A; Knezevic A; Sheinfeld J
    J Urol; 2024 Jan; 211(1):80-89. PubMed ID: 37672753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital.
    Sarikaya S; Karsiyakali N; Kaya E; Topuz B; Ebiloglu T; Zor M
    Actas Urol Esp (Engl Ed); 2021; 45(1):30-38. PubMed ID: 33010987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.
    Wood DP; Herr HW; Heller G; Vlamis V; Sogani PC; Motzer RJ; Fair WR; Bosl GJ
    J Urol; 1992 Dec; 148(6):1812-5; discussion 1815-6. PubMed ID: 1331547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desperation Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors.
    Carver BS
    Urol Clin North Am; 2015 Aug; 42(3):343-6. PubMed ID: 26216821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy.
    Liu J; Thomas B; Lawrentschuk N
    Eur Urol; 2023 Oct; 84(4):438-439. PubMed ID: 37385842
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Postchemotherapy Surgery in Germ Cell Tumors.
    Chéry L; Dash A
    Urol Clin North Am; 2015 Aug; 42(3):331-42. PubMed ID: 26216820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
    Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
    Konneh B; Lafin JT; Howard J; Gerald T; Amini A; Savelyeva A; Woldu SL; Lewis CM; Jia L; Margulis V; Coleman N; Scarpini C; Frazier AL; Murray MJ; Amatruda JF; Bagrodia A
    Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.